Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Government notifies...

    Government notifies Organ Preservative Solutions as DRUGS with immediate effect

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-04-04T11:13:13+05:30  |  Updated On 4 April 2019 11:13 AM IST
    Government notifies Organ Preservative Solutions as DRUGS with immediate effect

    New Delhi: In a move to monitor and assure quality Organ Preservative Solutions (OPS) the Government has specified OPS as "Drugs."


    Through a recent Gazette Notification, the Central Government has included Organ Preservative Solutions (OPS) to the list of notified medical devices placing it under the purview of Section 3 (b) (iv) of the Drugs and Cosmetics (D&C) Act 1940 with immediate effect.


    Section 3(b) of the Drugs and Cosmetics (D&C) Act 1940 talks about "drug" inclusive of such devices intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals.


    In pursuance of the same, the Government specified OPS intended for external or internal use in human beings as drugs. The notice reads;




    In pursuance of sub-clause (iv) of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government, after consultation with the Drugs Technical Advisory Board, hereby specifies the following device intended for external or internal use in human beings as drugs with immediate effect, namely:— “Organ preservative solution”



    Organ preservative solution (OPS) is a crucial medical device that is used to supply oxygen and vital nutrients to harvested organs, thereby increasing their life and maintaining their vitality.


    Commenting on the move MTaI Chairman Mr Pavan Choudary told Medical Dialogues, " Bringing this device under regulation will enable monitoring of its quality irrespective of the manufacturer. As a result of the regulation, supply of OPS of assured quality would be facilitated and the number of deaths due to organ failure will reduce as the solution enables storage and transportation of harvested organs to any location."


    Choudhary further spoke about similar steps that will help improve organ harvesting and transplant output immensely.


    "The government should now move on to the next measure in revolutionising organ transplantation in India. It should introduce an amendment to the Transplantation of Human Organs Act to make it mandatory for the doctor to remove those patients who are braindead off the ventilator. It will improve organ harvesting and transplant output immensely. Each such patient can save eight lives through organ donation," he added.


    A month ago, the Government had notified 8 medical devices as "drugs" including all implantable medical devices, CT scan, MRI equipment, defibrillators, dialysis machine, PET equipment, X-ray machine and bone marrow cell separator.


    Medical Dialogues had earlier reported that in a significant move to provide safety to patients and regulate the quality of diagnostic and medical devices in India, the health ministry had notified eight medical equipment, including all implantable devices, as “drugs” under Section 3 of the Drugs and Cosmetics Act, effective from April 1, 2020.


    Also Read: Eight medical devices including CT, MRI, X-ray notified as DRUGS by the health ministry

    CDSCOCentral Drugs Standard Control OrganisationCentral GovernmentCT scanD&C Act 1940defibrillatorsDialysis MachineDrug Technical Advisory BodyDrugs and Cosmeticshealthhealth carehealth care newshuman organMedical Device Rules 2017Medical Devicesmedical equipment listMRI equipmentnotified medical devicesOPSorganorgan preservative solutionsorgan transplantPET equipmentpharmapharma newspreservation solutionX-ray machine

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok